Cathie Wood Atai Life Sciences N.V. Transaction History

Ark Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	SELL	$1.17 - $2.7 $6.61 Million - $15.3 Million	-5,650,179 Reduced 99.77%	13,161 $23,000
Q4 2022 Jan 24, 2023	SELL	$2.38 - $3.55 $1.13 Million - $1.69 Million	-475,574 Reduced 7.75%	5,663,340 $0
Q3 2022 Oct 17, 2022	BUY	$3.14 - $4.87 $14.2 Million - $22 Million	4,519,879 Added 279.17%	6,138,914 $20.3 Million
Q2 2022 Jul 11, 2022	SELL	$3.03 - $5.32 $172,443 - $302,771	-56,912 Reduced 3.4%	1,619,035 $6.44 Million
Q1 2022 Apr 19, 2022	BUY	$4.66 - $7.66 $7.81 Million - $12.8 Million	1,675,947 New	1,675,947 $8.53 Million

12.4M

77.8K

50.3K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $197M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.